PHARMACYTE BIOTECH, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $704.4K | $90.6M | $85.4M |
| FY2023 | $586.6K | $73.3M | $68.0M |
| FY2024 | $20.4M | $59.9M | $50.2M |
| FY2025 | $3.3M | $55.2M | $15.2M |
| FY2026 | $11.8M | $46.8M | $18.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $704.4K | $90.6M | $85.4M |
| FY2023 | $586.6K | $73.3M | $68.0M |
| FY2024 | $20.4M | $59.9M | $50.2M |
| FY2025 | $3.3M | $55.2M | $15.2M |
| FY2026 | $11.8M | $46.8M | $18.6M |